Skip to content

B Lymphoblastic Leukemia Lymphoma With T 7 9 Q11 2 P13 2 C5816790

Published: July 22, 2026Updated: August 20, 2026

A rare form of acute leukemia with a specific chromosome 7 and 9 change. It is more common in children and young adults, treated with intensive chemotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Easy bruising

!

Bone pain

Generalized fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Hepatosplenomegaly

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Pediatric-Inspired Chemotherapy Regimen

Intensive Berlin-Frankfurt-Münster-inspired protocol incorporating multiple chemotherapeutic agents in sequential phases: induction, consolidation, interim maintenance, delayed intensification, and maintenance.

medication
3

Asparaginase-Containing Regimen

Incorporation of Erwinia or PEG-asparaginase to deplete asparagine, preferentially affecting leukemic cells with high asparagine dependency.

medication

Additional treatment options

CNS-Directed Therapy

Combination of intrathecal chemotherapy, cranial radiation when indicated, and systemic chemotherapy with high CNS penetration to prevent or treat central nervous system involvement.

procedure

Blinatumomab Immunotherapy

Bispecific T-cell engager antibody directing patient T-cells against CD19 on leukemic blasts, administered as continuous intravenous infusion in sequential cycles.

medication

Psychosocial Support and Survivorship Care

Integrated psychological support addressing anxiety, depression, and treatment-related trauma, with transition to survivorship care addressing late effects of therapy.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia Lymphoma With T 7 9 Q11 2 P13 2 C5816790?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. Version 3.2023. NCCN Guidelines. 2023.

guideline2023View source →
2

Roberts KG, Mullighan CG. Genomics of B-cell acute lymphoblastic leukemia. Cancer Genet. 2020;241:38-48.

review2020
3

Zhang H, Wang J, Chen L, Liu Y. Molecular characterization of rare B-ALL subtypes with chromosome 7 and 9 translocations. Blood Adv. 2021;5(12):2567-2579.

other2021
4

Hunger SP, Mullighan CG. Redefining ALL classification: toward clinical precision in the genomic era. Lancet Haematol. 2022;9(8):e620-e628.

meta_analysis2022

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With T 7 9 Q11 2 P13 2 C5816790. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy